NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
May 27, 2008 • Volume 5 / Number 11 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Studies Make Case for Finasteride to Prevent Prostate Cancer

Cancer Research Highlights
Potent Social Forces Influence Smoking Behavior

MRI May Contribute to Rising Mastectomy Rates

BRCA2 Linked to Prostate Cancer Incidence and Aggression

Vitamin D Not Associated with Decreased Prostate Cancer Risk

Director's Update
TCGA Moving Molecular Oncology Forward

Funding Opportunities

Spotlight
A New Cancer Specialty: Follow-up for Long-term Survivors

Legislative Update
House Panel Holds Hearing on Breast Cancer and Environment Legislation

Cancer.gov Update

Profiles in Cancer Research
Dr. Electra Paskett

Featured Clinical Trial
Selenium to Prevent Recurrence of Colorectal Polyps

Notes
In Memoriam: Longtime NCI Employee Judy Patt

Spring Research Festival Held at NCI-Frederick

NCI Cancer Bulletin Writer Wins NAGC Award

NCI@ASCO

Community Update
NCI Partners with Canary Foundation on Prostate Cancer Study

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Special Report Special Report

House Panel Holds Hearing on Breast Cancer and Environment Legislation

Cancer.gov Update

Last week, U.S. Senator Edward M. Kennedy of Massachusetts, a longtime champion of cancer research, was diagnosed with brain cancer. In recognition of an increase in public and media attention, NCI is highlighting the topic on the Cancer.gov home page. Please click this tile for more information on the disease:

Brain Tumors: Find Comprehensive Information

The U.S. House Energy and Commerce Subcommittee on Health held a May 21 hearing on legislation (H.R. 1157) to foster additional research at NIH on the possible environmental causes of breast cancer. Subcommittee Chairman Frank Pallone (D-NJ) noted that the legislation had been introduced in several previous Congressional sessions, and he and the sponsors of the bill hoped it would be passed without further delay.

Dr. Deborah Winn, chief of the Clinical and Genetic Epidemiology Research Branch in NCI's Division of Cancer Control and Population Sciences, testified that although the House bill is "well intended," it could have the "unintended consequence of narrowing the field of inquiry and promoting an unwise use of precious resources by mandating a specific way of conducting Federal research in breast cancer."

She stated that NIH and NCI already have sufficient authority to address this research area, noting that in FY 2008, "We expect $60.7 million will be specifically spent on researching the role of the environment in breast cancer development at NCI, and $35 million will be spent at the National Institute of Environmental Health Sciences, totaling almost $100 million in support of this important area across NIH."

Chairman Pallone noted that NIH had previously agreed to several revisions of the Senate version of the legislation (S.579). Dr. Winn reiterated that NIH did not oppose the Senate bill. S.579 was passed by the Senate Health, Education, Labor and Pensions Committee on February 27, 2008. Another witness, Fran Visco, president of the National Breast Cancer Coalition, said her group had negotiated with NIH on the revisions to the Senate bill. She and several House subcommittee members expressed hope that, with House concurrence to those revisions, the legislation may be passed during the current congressional session.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov